ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Neumora Therapeutics Inc

Neumora Therapeutics Inc (NMRA)

12.80
0.42
(3.39%)
Closed September 25 3:00PM
12.80
-0.01
(-0.08%)
After Hours: 3:08PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
12.80
Bid
12.50
Ask
13.65
Volume
894,838
12.00 Day's Range 12.94
8.33 52 Week Range 21.00
Market Cap
Previous Close
12.38
Open
12.32
Last Trade Time
Financial Volume
US$ 11,218,781
VWAP
12.5372
Average Volume (3m)
684,691
Shares Outstanding
160,027,746
Dividend Yield
-
PE Ratio
-8.69
Earnings Per Share (EPS)
-1.47
Revenue
-
Net Profit
-235.93M

About Neumora Therapeutics Inc

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, ... Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; NMRA-266 for the treatment of schizophrenia and other neuropsychiatric disorders; NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
New Castle, Delaware, USA
Founded
-
Neumora Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker NMRA. The last closing price for Neumora Therapeutics was US$12.38. Over the last year, Neumora Therapeutics shares have traded in a share price range of US$ 8.33 to US$ 21.00.

Neumora Therapeutics currently has 160,027,746 shares outstanding. The market capitalization of Neumora Therapeutics is US$1.98 billion. Neumora Therapeutics has a price to earnings ratio (PE ratio) of -8.69.

Neumora Therapeutics (NMRA) Options Flow Summary

Overall Flow

Bearish

Net Premium

-40k

Calls / Puts

0.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

NMRA Latest News

Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders

WATERTOWN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.079.1219096334211.7313.2111.73184007012.79150725CS
41.2210.535405872211.5813.2110.3587925012.19916854CS
123.0431.14754098369.7613.41059.5568469111.86597235CS
26-0.13-1.0054137664312.9314.958.3365377711.16730548CS
521.9618.081180811810.84218.3349987812.23291324CS
156-3.7-22.424242424216.5218.3351297612.27003083CS
260-3.7-22.424242424216.5218.3351297612.27003083CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RZLVRezolve AI Ltd
US$ 7.44
(51.22%)
3.17M
RNAZTransCode Therapeutics Inc
US$ 0.63
(51.12%)
12.73M
ATGLAlpha Technology Group Limited
US$ 2.16
(49.72%)
3.42M
INVZWInnoviz Technologies Ltd
US$ 0.18
(45.69%)
11.02k
OCTOEightco Holdings Inc
US$ 3.61
(44.98%)
100.6M
VTNRVertex Energy Inc
US$ 0.1501
(-58.42%)
49.72M
CMCTCreative Media and Community Trust Corporation
US$ 0.71
(-54.63%)
3.56M
SFIXStitch Fix Inc
US$ 2.28
(-39.20%)
23.88M
SHOTWSafety Shot Inc
US$ 0.22
(-31.25%)
11.82k
ARQQArqit Quantum Inc
US$ 4.40
(-29.63%)
438.63k
NVDANVIDIA Corporation
US$ 123.51
(2.18%)
284.49M
MLGOMicroAlgo Inc
US$ 0.2744
(26.92%)
142.29M
SQQQProShares UltraPro Short QQQ
US$ 7.47
(-2.35%)
124.15M
CEROCERo Therapeutics Holdings Inc
US$ 0.0986
(5.23%)
123.59M
INTCIntel Corporation
US$ 23.54
(3.20%)
117.01M

Your Recent History

Delayed Upgrade Clock